AMENDMENT TO THE ESCROW AGREEMENT (the “Amendment”)Escrow Agreement • April 10th, 2009 • Mabcure Inc. • In vitro & in vivo diagnostic substances
Contract Type FiledApril 10th, 2009 Company IndustryTHIS AMENDMENT, is made and entered into as of April 2, 2009, by and among MabCure Inc. (the “Company”), Dr. Amnon Gonenne (the “Executive”), and, Clark Wilson LLP (the “Escrow Agent”). (Together the “Parties”, and each individually, a “Party”).
AMENDMENT TO THE ASSET PURCHASE AGREEMENT (the “Amendment”)Asset Purchase Agreement • April 10th, 2009 • Mabcure Inc. • In vitro & in vivo diagnostic substances
Contract Type FiledApril 10th, 2009 Company IndustryTHIS AMENDMENT, is made and entered into as of April 2, 2009, by and among MabCure Inc. (f/k/a Smartec Holdings Inc.), (“Pubco”), Indigoleaf Associates Ltd. (the “Vendor”), and Dr. Amnon Gonenne (the “Executive”). (Together the “Parties”, and each individually, a “Party”).
AMENDMENT TO THE EMPLOYMENT AGREEMENT (the “Amendment”)Employment Agreement • April 10th, 2009 • Mabcure Inc. • In vitro & in vivo diagnostic substances
Contract Type FiledApril 10th, 2009 Company IndustryTHIS AMENDMENT, is made and entered into as of April 2, 2009, by and between MabCure Inc., (the “Company”), and Dr. Amnon Gonenne (the “Executive”). (Together the “Parties”, and each individually, a “Party”).